The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
1 pt

Opinion on  Dendreon Corp (DNDN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Bearish on Dendreon Corp

May 12, 2009 04:58 AM GMT
Return Risk
+12.74% HIGH
Associate

Fundamental Analysis  

           Uptrend on DNDN will not last long, unless actual profit shows up on this stock. High debt-to-equity (over 8 times to equty) and weak balance sheet, consistent negative return on income.  Stay away from this junk.

DNDN:  This call was made on 05/12/09 @ $21.03
Rating:   Negative   $21.03 (05/12/09)
Gain/Loss:   -29.24% in 208 days
Target:   $10.00 (-52.45%) in Six months


Comments (1)

Add Comment

Arrow_up
Arrow_down
fredbear09   N/A     0 point   commented 208 days ago reply

you obviously have not been following the details of their almost certain approval for a drug that has the potential for $1-2 Billion in sales. Yes, it is still speculative, but junk...absolutely not.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
WM Washington Mutual Inc
FNM Fannie Mae
PG The Procter & Gamble Company
BA The Boeing Company
AAPL Apple Computer Inc
GOOG Google Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Dendreon Corp (DNDN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
76.0%
Top:
75.0%




Latest Picks by william0509
Symbol SP Sentiment Rating Return Since
EP Negative +2.06% 07/22/09
CAL Negative -58.09% 07/16/09
DOV Positive +23.63% 07/01/09
DCI Positive +20.55% 06/27/09
CDNS Negative -9.36% 06/23/09

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch